Worldwide Clinical Trials India Private Limited

Provides drug development and clinical research services to pharmaceutical and biotechnology industries.

2012 | Mumbai, Maharashtra (India) | Active
Last Updated:

Worldwide Clinical Trials India Profile

Key Indicators

  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 13 Year, 3 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth %
  • Profit Growth 1218.12%
  • Total Assets %

About Worldwide Clinical Trials India

Worldwide Clinical Trials India Private Limited (WCTIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 19 January 2012 and has a history of 13 years and three months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.

Vishal Aggarwal and Karen Russell serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74120MH2012FTC226192

  • Company No.

    226192

  • Company Classification

    Private Limited Foreign Company Incorporated In India

  • Incorporation Date

    19 Jan 2012

  • Date of AGM

    29 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma
Company report

Worldwide Clinical Trials India Private Limited

Explore comprehensive data for Worldwide Clinical Trials India Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Worldwide Clinical Trials India?

Board Members (2)

NameDesignationAppointment DateStatus
Vishal Aggarwal Country flag representing In Director 12-Sep-2022Current
Karen Russell Country flag representing Gb Director 20-Jun-2019Current

Financial Performance of Worldwide Clinical Trials India.

Worldwide Clinical Trials India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1218.12% increase in profit. The company's net worth witnessed no change by increase of 0%.

Worldwide Clinical Trials India revenue growth over time
Worldwide Clinical Trials India profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
1218.12%
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Worldwide Clinical Trials India?

In 2022, Worldwide Clinical Trials India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Worldwide Clinical Trials India?

Unlock and access historical data on people associated with Worldwide Clinical Trials India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Worldwide Clinical Trials India Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Worldwide Clinical Trials India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Worldwide Clinical Trials India's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Worldwide Clinical Trials India

Recent activity within the organization

  • Annual General Meeting

    Worldwide Clinical Trials India Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Worldwide Clinical Trials India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

  • Director Appointment

    Vishal Lochan Aggarwal was appointed as a Director was appointed as a Director on 12 Sep 2022 & has been associated with this company since 2 years 7 months .

  • Director Appointment

    Karen Jane Russell was appointed as a Director was appointed as a Director on 20 Jun 2019 & has been associated with this company since 5 years 10 months .

  • Company Incorporation

    Worldwide Clinical Trials India Private Limited was registered on 19 Jan 2012 with Roc Mumbai & aged 13 years 3 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Worldwide Clinical Trials India Private Limited?

    Worldwide Clinical Trials India Private Limited was incorporated on 19 Jan 2012.

  • What is authorized share capital and paid-up capital of Worldwide Clinical Trials India Private Limited?

    The authorized share capital of Worldwide Clinical Trials India Private Limited is ₹ 2.50 M and paid-up capital is ₹ 2.50 M.

  • Who are the current board members & directors of Worldwide Clinical Trials India Private Limited?

    Currently 2 directors are associated with Worldwide Clinical Trials India Private Limited.

    • Vishal Lochan Aggarwal
    • Karen Jane Russell

  • What is the registered address of Worldwide Clinical Trials India Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Worldwide Clinical Trials India Private Limited is Unit No.9 9Th Floor Corporate Park Ii Vn Purav Marg Near Swastik Chambers Park, Chembur India, Mumbai, Maharashtra, 400071.

  • What is the corporate identification number (CIN) and company number of Worldwide Clinical Trials India Private Limited?

    The corporate identification number (CIN) of Worldwide Clinical Trials India Private Limited is U74120MH2012FTC226192 and the company number is 226192 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Worldwide Clinical Trials India Private Limited?

    The Official website of Worldwide Clinical Trials India Private Limited is https://www.worldwide.com

  • When was the last Balance Sheet of Worldwide Clinical Trials India Private Limited filed with the ROC?

    The most recent Balance Sheet for Worldwide Clinical Trials India Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharma Contract R&D